Skip to main content

Search

Language & Country Selector for Desktop

Choose Location

International
Americas
Asia Pacific
Europe
Middle East & Africa

: Global | en
: Sandoz | en
: Novartis Foundation | en

: Argentina | es
: Brazil | pt
: Canada | en
: Canada | fr
: Central America | es
: Colombia | es
: Mexico | es
: United States | en
: Venezuela | es

: Australia | en
: Bangladesh | en
: Hong Kong S.A.R. | zh
: India | en
: Indonesia | en
: Japan | ja
: Korea | ko
: Mainland China | zh
: Malaysia | en
: Pakistan | en
: Philippines | en
: Singapore | en
: Taiwan | zh

: Austria | de
: Belgium | fr
: Belgium | nl
: Bulgaria | bg
: Czech Republic | cs
: Czech Republic | en
: Denmark | da
: Estonia | et
: Finland | fi
: France | fr
: Germany | de
: Greece | el
: Hungary | hu
: Ireland | en
: Italy | it
: Latvia | lv
: Lithuania | lt
: Netherlands | nl
: Norway | no
: Poland | pl
: Portugal | pt
: Romania | ro
: Russia | ru
: Serbia | sr
: Slovakia | sk
: Spain | es
: Sweden | sv
: Switzerland | de
: Switzerland | fr
: United Kingdom | en

: Egypt | en
: Israel | he
: South Africa | en
: Turkey | tr

Language & Country Selector for Mobile

Choose Location

International Americas Asia Pacific Europe Middle East & Africa

About

Board of Directors

Joerg Reinhardt

Simon Moroney

Nancy C. Andrews

Ton Buechner

Patrice Bula

Elizabeth (Liz) Doherty

Ana de Pro Gonzalo

Bridgette Heller

Daniel Hochstrasser

Frans van Houten

Charles L. Sawyers

William T. Winters

John D. Young

Charlotte Pamer-Wieser

Executive Committee

Vasant (Vas) Narasimhan

Shreeram Aradhye

Victor Bulto

Aharon (Ronny) Gal

Karen L. Hale

Harry Kirsch

Rob Kowalski

Steffen Lang

Fiona Marshall

Klaus Moosmayer

Marie-France Tschudin

Lutz Hegemann

Kees Roks

Richard Saynor

Michael Willi

Strategy

People and Culture

Data and Digital

Products

Innovative Medicines

Therapeutic areas

Cancer

Hematology

Sandoz

Diversity, Equity & Inclusion

Equity

Diversity, Equity & Inclusion Governance and Community

Inclusivity

Parental Leave

Society

Manufacturing

Quality

Audit program

Novartis Quality Management System (QMS)

Product and patient safety training

Regulatory inspections

Product recalls

Third-party suppliers

Awards and Recognition

About

Learn about how Novartis is organized and our strategy, vision and mission. Meet our people and read about our commitments to diversity, equity and inclusion. Explore our history which goes back more than 250 years.

Patients and Caregivers

Novartis Commitment to Patients and Caregivers

Diseases

Patient Organization Funding

Stories: Patients Perspectives

Patients and Caregivers

Information for patients and their caregivers including clinical trial recruiting, managed access programs, funding opportunities for patient organizations and side effects reporting.

Healthcare Professionals

Medical Congresses and Events

Abstract summaries for EULAR

Abstract summaries for ACR

ASCO Annual Meeting

Products

Novartis Pipeline

Managed Access Programs

Novartis Gene Therapies Managed Access Program

Novartis External Funding

Healthcare Professional Resources by Country

Investigator-Initiated Trials / Studies

Transparency and Disclosure

Novartis Medical Information

Submit medical enquiry

Healthcare Professionals

Resources for physicians and other healthcare professionals including clinical trial recruiting, grant funding, congresses and country-level information.

Research & Development

Novartis Institutes for BioMedical Research

Collaborations

NIBR Global Scholars Program

Technology Platforms

Radioligand Therapy

Gene Therapy

Cell Therapy

Research Disease Areas

Cardiovascular and metabolic disease research at Novartis

DAx: exploratory disease research at Novartis

Global Health disease area research at Novartis

Immunology disease research at Novartis

Neuroscience research at Novartis

Oncology research at Novartis

Ophthalmology research at Novartis

Research Locations

Novartis Pipeline

Translational Medicine

Research Collaborations

Open Source Science

Stories from our Labs

Research & Development

Discover how Novartis turns breakthrough science into transformative, high-value treatments. Learn about our innovation engine, the Novartis Institutes for BioMedical Research (NIBR) and explore our research areas, technology platforms and pipeline.

ESG

Access

Creating sustainable business models

Value-Based Pricing

Sub-Saharan Africa

Donations

Novartis Access Principles

Novartis Oncology Access

Patents and Licensing

Ethics, Risk and Compliance

Ethical Behavior

Compliance

Human Rights

Learning and Engagement

Risk management

Environmental Sustainability

Climate

Waste

Water

Global Health

Anti-Microbial Resistance (AMR)

Avoidable Blindness

Chagas Disease

Leprosy

Malaria

Sickle Cell Disease (SCD)

Novartis Foundation

Diversity, Equity & Inclusion

Reporting

ESG Rating Performance

Codes, Policies and Guidelines

Materiality Assessment

Transparency and Disclosure

Targets

Positions

ESG Index

Environmental, Social and Governance

Learn about our commitments to making a positive impact on the world by providing access to innovative medicines, protecting the environment, and upholding high ethical standards. Explore the Novartis in Society Integrated Report.

Investors

Event Calendar

Financial Data

Novartis Annual Results

Novartis Quarterly Results

Novartis SEC Filings

Product Sales

Fixed-Income Securities

Expected Currency Impact

Share Data & Analysis

Share Monitor

Dividend Information

Share Ownership

Share Overview

Return On Investment Calculator

Shareholder Information

General Meetings

American Depository Receipts (ADR)

Share Buy-Back

Frequently Asked Questions

Company Overview

Corporate Governance

Novartis Annual Reporting Suite

Reporting Archive

Publications Order Form

ESG

Investors

Updates and resources for investors including financial information, disclosures, events, share price, ESG and reporting.

News

News Archive

Media Library

Stories

Subscribe

News

Information for journalists including media releases, statements, stories, multimedia resources and more.

Careers

Career Search

Benefits & Rewards

Career Programs

Community Exploration & Learning Lab (CELL)

Postdoc Program

Early Careers

Careers in Data, Digital & Information Technology (IT)

Careers in Manufacturing and Supply

US NIBR Internship Programs

Personal Growth

Wellbeing

Careers

Novartis is hiring! Find open positions, learn more about our strategy and culture, and apply today.

Clinical Trials

Clinical Trials

Find recruiting clinical trials and learn more about how to participate or work with Novartis on clinical studies. Read about our clinical trials transparency initiatives.

Partnering

Partnering

Learn about our approach to partnering which combines capabilities, collaboration and culture.

Supplier Portal

Supplier Portal

Practical information and resources for suppliers around the world.

Report side effects

Reporting side effects

Let us know about any unwanted medical occurrences.

Contacts

Contacts

Get in touch.
Home

Welcome to Novartis where we are reimagining medicine to improve and extend people’s lives.

Home
News
Supply chain organization during the COVID-19 pandemic

Supply chain organization during the COVID-19 pandemic

Aug 28, 2020

Balancing priorities of combating the crisis and ongoing trials.

Aug 28, 2020

Print
PDF

Novartis

Navigate Novartis

Patients and Caregivers
Healthcare Professionals
Researchers
Job Seekers
Journalists
Investors
Partners
Suppliers

Topics

Clinical Trials
ESG
SpeakUp

Explore

Novartis Pipeline
Products
Therapeutic areas
Diseases
Stories
Locations

Novartis companies

Sandoz
Advanced Accelerator Applications
Gyroscope Therapeutics

Search

Footer Bottom

© 2023 Novartis AG

Terms of Use
Privacy
Contacts
Cookie Settings
Site Map
Web Accessibility
Open Source

Novartis Site Directory

This site is intended for a global audience